{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:16:22Z","timestamp":1790914582674,"version":"4.1.0"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T00:00:00Z","timestamp":1587945600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Autosomal dominant polycystic kidney disease (ADPKD) is linked with risk for posttransplantation diabetes mellitus (PTDM), but this association has methodologic limitations like diagnostic criteria. The aim of this study was to use contemporary diagnostic criteria for PTDM and explore any risk association for kidney transplant recipients with ADPKD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>We undertook a retrospective analysis of 1560 nondiabetic kidney transplant recipients between 2007 and 2018 at a single center, of whom 248 (15.9%) had ADPKD. Local\/national data were linked for every patient, with manual data capture of PTDM diagnosis by International Consensus Recommendations. We then pooled our data with eligible studies after an updated systematic review and performed a meta-analysis to estimate the pooled effect.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>Comparing ADPKD versus non-ADPKD kidney transplant recipients, PTDM risk was not significantly different at our center (19.4% versus 14.9%, respectively; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.085). ADPKD patients who developed PTDM were older, borderline heavier, and less likely to be recipients of living kidney donor compared with ADPKD patients who remained free of PTDM. Systematic review of the literature identified 14 eligible studies, of which 8 had a PTDM diagnosis consistent with Consensus recommendations. In the meta-analysis, we observed an increased odds ratio (OR) of kidney transplant recipients with ADPKD developing PTDM regardless of all study inclusion (OR, 1.98; 95% confidence interval, 1.43-2.75) or restricted study inclusion based on robust PTDM diagnostic criteria (OR, 1.81; 95% confidence interval, 1.16-2.83).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>ADPKD kidney transplant candidates should be counseled of their increased risk for PTDM, with further work warranted to investigate any underlying metabolic pathophysiology.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/txd.0000000000000989","type":"journal-article","created":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T22:42:13Z","timestamp":1588286533000},"page":"e553","source":"Crossref","is-referenced-by-count":15,"title":["Autosomal Dominant Polycystic Kidney Disease Is a Risk Factor for Posttransplantation Diabetes Mellitus: An Updated Systematic Review and Meta-analysis"],"prefix":"10.1097","volume":"6","author":[{"given":"Alice","family":"Culliford","sequence":"first","affiliation":[{"name":"Department of Nephrology and Transplantation, Queen Elizabeth Hospital, Birmingham, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuvreen","family":"Phagura","sequence":"additional","affiliation":[{"name":"University of Birmingham, Birmingham, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Sharif","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Transplantation, Queen Elizabeth Hospital, Birmingham, United Kingdom."},{"name":"Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,5]]},"reference":[{"key":"R1-20231127","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(18)32782-X","article-title":"Autosomal dominant polycystic kidney disease.","volume":"393","author":"Cornec-Le Gall","year":"2019","journal-title":"Lancet"},{"key":"R2-20231127","first-page":"1356","article-title":"Prevalence of autosomal dominant polycystic kidney disease in the European Union.","volume":"32","author":"Willey","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"R3-20231127","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrneph.2014.104","article-title":"Renal transplantation in autosomal dominant polycystic kidney disease.","volume":"10","author":"Kanaan","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"R4-20231127","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/ndt\/gfu044","article-title":"Metabolic abnormalities in autosomal dominant polycystic kidney disease.","volume":"30","author":"Mao","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"R5-20231127","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S2213-8587(15)00387-3","article-title":"Post-transplantation diabetes-state of the art.","volume":"4","author":"Sharif","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R6-20231127","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1111\/ajt.12850","article-title":"Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions.","volume":"14","author":"Sharif","year":"2014","journal-title":"Am J Transplant"},{"key":"R7-20231127","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/ndt\/14.5.1244","article-title":"Polycystic kidney disease as a risk factor for post-transplant diabetes mellitus.","volume":"14","author":"Ducloux","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"R8-20231127","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/ndt\/17.5.887","article-title":"Incidence of diabetes mellitus requiring insulin treatment after renal transplantation in patients with hepatitis C.","volume":"17","author":"Gentil","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"R9-20231127","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/j.1523-1755.2005.67132.x","article-title":"Autosomal-dominant polycystic kidney disease as a risk factor for diabetes mellitus following renal transplantation.","volume":"67","author":"de Mattos","year":"2005","journal-title":"Kidney Int"},{"key":"R10-20231127","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/01.tp.0000248759.37146.3d","article-title":"Polycystic kidney disease is a risk factor for new-onset diabetes after transplantation.","volume":"83","author":"Hamer","year":"2007","journal-title":"Transplantation"},{"key":"R11-20231127","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.arcmed.2007.10.003","article-title":"Autosomal dominant polycystic kidney disease is not a risk factor for post-transplant diabetes mellitus. Matched-pair design multicenter study.","volume":"39","author":"Pietrzak-Nowacka","year":"2008","journal-title":"Arch Med Res"},{"key":"R12-20231127","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.transproceed.2009.01.069","article-title":"Autosomal-dominant polycystic kidney disease and kidney transplantation: experience of a single center.","volume":"41","author":"Gon\u00e7alves","year":"2009","journal-title":"Transplant Proc"},{"key":"R13-20231127","first-page":"1038","article-title":"The risk factors for diabetes mellitus after kidney transplantation.","volume":"21","author":"Razeghi","year":"2010","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"R14-20231127","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1432-2277.2011.01237.x","article-title":"Outcomes of renal transplantation in patients with autosomal dominant polycystic kidneydisease: a nationwide longitudinal study.","volume":"24","author":"Jacquet","year":"2011","journal-title":"Transpl Int"},{"key":"R15-20231127","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1399-0012.2010.01367.x","article-title":"Impact of pre-transplant dialysis modality on post-transplant diabetes mellitus after kidney transplantation.","volume":"25","author":"Courivaud","year":"2011","journal-title":"Clin Transplant"},{"key":"R16-20231127","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/TP.0b013e31820f0877","article-title":"Incidence and risk factors of glucose metabolism disorders in kidney transplant recipients: role of systematic screening by oral glucose tolerance test.","volume":"91","author":"Caillard","year":"2011","journal-title":"Transplantation"},{"key":"R17-20231127","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijt.2012.07.003","article-title":"New onset diabetes after transplantation (NODAT): analysis of pre-transplant risk factors in renal allograft recipients.","volume":"6","author":"Prakash","year":"2012","journal-title":"Indian J Transplant"},{"key":"R18-20231127","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1440-1797.2011.01507.x","article-title":"New onset diabetes after kidney transplantation in autosomal dominant polycystic kidney disease: a retrospective cohort study.","volume":"17","author":"Ruderman","year":"2012","journal-title":"Nephrology (Carlton)"},{"key":"R19-20231127","doi-asserted-by":"crossref","first-page":"791","DOI":"10.7196\/SAMJ.2017.v107i9.12258","article-title":"New-onset diabetes after transplant: incidence, risk factors and outcome.","volume":"107","author":"Alagbe","year":"2017","journal-title":"S Afr Med J"},{"key":"R20-20231127","first-page":"676","article-title":"Posttransplant outcomes of patients with autosomal dominant polycystic kidney disease versus other recipients: a 10-year report from south of Iran.","volume":"16","author":"Roozbeh","year":"2018","journal-title":"Exp Clin Transplant"},{"key":"R21-20231127","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jcjd.2016.03.001","article-title":"The risk for new-onset diabetes mellitus after kidney transplantation in patients with autosomal dominant polycystic kidney disease: a systematic review and meta-analysis.","volume":"40","author":"Cheungpasitporn","year":"2016","journal-title":"Can J Diabetes"},{"key":"R22-20231127","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation.","volume":"357","author":"Ekberg","year":"2007","journal-title":"N Engl J Med"},{"key":"R23-20231127","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/ajt.14625","article-title":"The Banff 2017 kidney meeting report: revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials.","volume":"18","author":"Haas","year":"2018","journal-title":"Am J Transplant"},{"key":"R24-20231127","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"R25-20231127","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ki.1997.360","article-title":"Insulin resistance in adult polycystic kidney disease.","volume":"52","author":"Vareesangthip","year":"1997","journal-title":"Kidney Int"},{"key":"R26-20231127","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3109\/00365513.2010.527012","article-title":"Glucose metabolism parameters during an oral glucose tolerance test in patients with autosomal dominant polycystic kidney disease.","volume":"70","author":"Pietrzak-Nowacka","year":"2010","journal-title":"Scand J Clin Lab Invest"},{"key":"R27-20231127","doi-asserted-by":"crossref","first-page":"5308","DOI":"10.1038\/ncomms6308","article-title":"Ciliary dysfunction impairs beta-cell insulin secretion and promotes development of type 2 diabetes in rodents.","volume":"5","author":"Gerdes","year":"2014","journal-title":"Nat Commun"},{"key":"R28-20231127","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/S0002-9440(10)65428-4","article-title":"Coordinate expression of the autosomal dominant polycystic kidney disease proteins, polycystin-2 and polycystin-1, in normal and cystic tissue.","volume":"154","author":"Ong","year":"1999","journal-title":"Am J Pathol"},{"key":"R29-20231127","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nm.3092","article-title":"Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy.","volume":"19","author":"Rowe","year":"2013","journal-title":"Nat Med"},{"key":"R30-20231127","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00439-006-0197-y","article-title":"Phenotypic characterization of Bbs4 null mice reveals age-dependent penetrance and variable expressivity.","volume":"120","author":"Eichers","year":"2006","journal-title":"Hum Genet"},{"key":"R31-20231127","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1159\/000260042","article-title":"Metabolic syndrome components in patients with autosomal-dominant polycystic kidney disease.","volume":"32","author":"Pietrzak-Nowacka","year":"2009","journal-title":"Kidney Blood Press Res"},{"key":"R32-20231127","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1093\/ndt\/gfr744","article-title":"The impact of type II diabetes mellitus in patients with autosomal dominant polycystic kidney disease.","volume":"27","author":"Reed","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R33-20231127","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1053\/j.ajkd.2012.02.339","article-title":"Important outcomes for kidney transplant recipients: a nominal group and qualitative study.","volume":"60","author":"Howell","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"R34-20231127","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nrneph.2011.174","article-title":"Complications associated with new-onset diabetes after kidney transplantation.","volume":"8","author":"Sharif","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"R35-20231127","article-title":"Comparing glycaemic benefits of active versus passive lifestyle intervention in kidney allograft recipients (CAVIAR): a randomised controlled trial.","author":"Kuningas","year":"2019","journal-title":"Transplantation"},{"key":"R36-20231127","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/TP.0b013e3181c518cc","article-title":"Steroid avoidance or withdrawal after renal transplantation increases the risk of acute rejection but decreases cardiovascular risk. A meta-analysis.","volume":"89","author":"Knight","year":"2010","journal-title":"Transplantation"},{"key":"R37-20231127","first-page":"CD005632","article-title":"Steroid avoidance or withdrawal for kidney transplant recipients.","author":"Haller","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"R38-20231127","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1111\/ajt.13247","article-title":"New-onset diabetes after transplantation: results from a double-blind early corticosteroid withdrawal trial.","volume":"15","author":"Pirsch","year":"2015","journal-title":"Am J Transplant"},{"key":"R39-20231127","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.ekir.2018.07.009","article-title":"Randomized controlled trial assessing the impact of tacrolimus versus cyclosporine on the incidence of posttransplant diabetes mellitus.","volume":"3","author":"Torres","year":"2018","journal-title":"Kidney Int Rep"},{"key":"R40-20231127","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1681\/ASN.2009121302","article-title":"Sirolimus therapy to halt the progression of ADPKD.","volume":"21","author":"Perico","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R41-20231127","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJMoa0907419","article-title":"Sirolimus and kidney growth in autosomal dominant polycystic kidney disease.","volume":"363","author":"Serra","year":"2010","journal-title":"N Engl J Med"},{"key":"R42-20231127","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1003491","article-title":"Everolimus in patients with autosomal dominant polycystic kidney disease.","volume":"363","author":"Walz","year":"2010","journal-title":"N Engl J Med"},{"key":"R43-20231127","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2215\/CJN.09900915","article-title":"Effect of sirolimus on disease progression in patients with autosomal dominant polycystic kidney disease and CKD stages 3b-4.","volume":"11","author":"Ruggenenti","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"R44-20231127","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1681\/ASN.2007111202","article-title":"Sirolimus is associated with new-onset diabetes in kidney transplant recipients.","volume":"19","author":"Johnston","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R45-20231127","doi-asserted-by":"crossref","first-page":"g6679","DOI":"10.1136\/bmj.g6679","article-title":"Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data.","volume":"349","author":"Knoll","year":"2014","journal-title":"BMJ"},{"key":"R46-20231127","doi-asserted-by":"crossref","first-page":"g6808","DOI":"10.1136\/bmj.g6808","article-title":"Sirolimus after kidney transplantation.","volume":"349","author":"Sharif","year":"2014","journal-title":"BMJ"},{"key":"R47-20231127","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1097\/TP.0000000000002291","article-title":"Belatacept in solid organ transplant: review of current literature across transplant types.","volume":"102","author":"Perez","year":"2018","journal-title":"Transplantation"}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000000989","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T22:07:43Z","timestamp":1701122863000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000000989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,27]]},"references-count":47,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000000989","relation":{},"ISSN":["2373-8731"],"issn-type":[{"value":"2373-8731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,27]]}}}